Q2 2015 Holdings
Filed 2015-08-12 | 116 holdings | $272.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $142.7M | 353,233 | 52.4% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $73.2M | 534,977 | 26.9% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $24.3M | 1,778,200 | 8.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $15.5M | 370,000 | 5.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $12.4M | 103,495 | 4.6% |
| Cellectis S.A.(CLLS) | Sponsored ADS | 15117K103 | $1.4M | 40,000 | 0.5% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $504.0K | 27,500 | 0.2% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $243.5K | 2,079,731 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $223.3K | 1,929,234 | 0.1% |
| Mylan NV | Shares Euro | N59465109 | $124.7K | 1,837,005 | 0.0% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $110.9K | 897,903 | 0.0% |
| Alexion Pharmaceuticals plc(ALXN) | Common | 015351109 | $105.6K | 584,305 | 0.0% |
| Allergan plc | Shares | G0177J108 | $104.3K | 343,686 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $95.5K | 187,166 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $91.8K | 880,461 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $86.2K | 884,612 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $82.0K | 1,387,594 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $76.3K | 497,280 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $66.6K | 1,035,470 | 0.0% |
| Pfizer, Inc.(PFE) | Common | 717081103 | $54.9K | 1,638,241 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $50.1K | 229,641 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $42.3K | 331,931 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $37.1K | 849,482 | 0.0% |
| Bristol-Myers Squibb Co.(BMY) | Common | 110122108 | $35.6K | 535,240 | 0.0% |
| Catamaran Corporation | Common | 148887102 | $26.5K | 433,600 | 0.0% |
| Endo International PLC | Shares | G30401106 | $26.0K | 325,873 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $24.5K | 347,901 | 0.0% |
| Receptos, Inc. | Common | 756207106 | $23.7K | 124,800 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $22.7K | 680,862 | 0.0% |
| Amgen Inc.(AMGN)Call | Common | 031162100 | $22.4K | 146,000 | 0.0% |
| Baxter International, Inc.(BAX) | Common | 071813109 | $22.4K | 319,600 | 0.0% |
| Humana, Inc.(HUM) | Common | 444859102 | $21.4K | 112,000 | 0.0% |
| Ishares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $21.3K | 57,670 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $21.2K | 120,357 | 0.0% |
| HCA Holdings, Inc.(HCA) | Common | 40412C101 | $19.4K | 213,788 | 0.0% |
| Ventas Inc.(VTR) | Common | 92276F100 | $18.2K | 292,782 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $18.0K | 375,860 | 0.0% |
| Paratek Pharmaceuticals, Inc. | Common | 699374302 | $17.8K | 691,000 | 0.0% |
| Physicians Realty Trust(DOCUSD) | Common | 71943U104 | $16.1K | 1,050,902 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $15.8K | 344,683 | 0.0% |
| Corsicanto Ltd. | Note 3.5% 1/15/32 | 220480AB3 | $15.8K | $14,700,000 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $15.7K | 297,901 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $15.3K | 67,862 | 0.0% |
| Medical Properties Trust Inc.(MPT) | Common | 58463J304 | $15.1K | 1,153,574 | 0.0% |
| Omega Healthcare Investors Inc.(OHI) | Common | 681936100 | $14.2K | 413,116 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | Common | 427746102 | $13.6K | 436,970 | 0.0% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $13.2K | 209,572 | 0.0% |
| Karyopharm Therapeutics Inc.(KPTIEUR) | Common | 48576U106 | $13.0K | 476,966 | 0.0% |
| Esperion Therapeutics, Inc.(ESPR)Call | Common | 29664W105 | $12.1K | 148,000 | 0.0% |
| Esperion Therapeutics, Inc.(ESPR) | Common | 29664W105 | $12.1K | 148,000 | 0.0% |